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Background
Risk prediction for sudden death remains imperfect in
HCM. We compared CMR-derived LV fibrosis and strain
measures to outcomes in a cohort of HCM patients.
Methods
Consecutive patients undergoing CMR on identical 1.5
Tesla scanners to evaluate HCM were identified at a ter-
tiary referral center. LV fibrosis was measured using a
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previously validated iterative technique (cmr42, Circle
Cardiovascular Imaging) from LGE images acquired
using standard inversion recovery techniques. LV
volume, mass and EF were assessed from contiguous
short axis SSFP cines. LV circumferential and radial
strain were measured from a single mid-SAX SSFP cine
(Trufi Strain, Siemens). Sustained VT/VF, ICD place-
ment, appropriate ICD therapy, CHF admission, septal
reduction and/or death comprised the Event Group, n =
13 and those without the No Event Group, n = 34.
Baseline characteristics were reported as mean ± SD for
continuous variables and frequencies for categorical vari-
ables with group differences examined by t and c2 tests.
A Shapiro-Wilk test was used to evaluate normality and a
Wilcoxon-Kruskal-Wallis test was used for non normal
distributions. Linear regression analysis evaluated the
independent association of predictive variables and recei-
ver operator curves were generated (JMP, SAS).
Results
At a median of 12 months post-CMR, 13 of 47 identi-
fied patients experienced an event (Figure 1). While pre-
valence of traditional risk markers was similar in both
groups, myocardial scar burden was significantly greater
in those with vs without events (23.0 [10.0-66.5] vs 12.0
[6.0-22.2] g, p = 0.024) as was maximum wall thickness
(2.3 [2.1-2.9] vs 2.0 [1.6-2.3] cm, p = 0.004). Peak systo-
lic strain was significantly lower in those with events,
both radial (35.4 ± 9.7 vs 51.4 ± 13.2 %, p < 0.001) and
circumferential (-14.9 ± 3.5 vs -19.3 ± 4.1 %, p =
0.0024). Peak radial strain, peak circumferential strain
and WT had the largest AUCs (0.83, 0.79 and 0.77
respectively (Figure 2).
Conclusions
LV strain, fibrosis burden and wall thickness contri-
bute to risk stratification in HCM beyond clinical pre-
dictors. These findings support further studies to
develop multivariable prediction models that incorpo-
rate multiple CMR measures.
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Figure 2 ROC AUC.
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